A sale could value Amoun at $700 million to $800 million, Bloomberg reported. (http://bloom.bg/1EXe5PQ)
Valeant in talks to buy Egyptian drugmaker Amoun Pharma: Bloomberg
(Reuters) - Valeant Pharmaceuticals International Inc is in talks to buy Egyptian drugmaker Amoun Pharmaceutical Co to expand its veterinary and human medicines portfolio, Bloomberg reported, citing people familiar with the matter.
The sign of Valeant Pharmaceuticals International Inc is seen at its headquarters in Laval, Quebec May 19, 2015. REUTERS/Christinne Muschi
Recommended articles
Valeant was not immediately available for comment.
Should Amoun fail to find a buyer, it may consider an initial public offering in London, the report said.
Amoun could not be immediately reached for comment.
JOIN OUR PULSE COMMUNITY!
ADVERTISEMENT
Eyewitness? Submit your stories now via social or:
Email: eyewitness@pulse.ng
Recommended articles
Russia sends new military equipment to Niger as relationship waxes strong
Parents, lecturers disagree over 18 years university admission age
Prince Harry, Meghan are in 'competition' over Nigeria
Israeli Cabinet votes to close down Al Jazeera’s operations
Driver dies after vehicle crashes into White House gate
Shehu Sani vows to never reconcile with El-Rufai because of these 5 ‘great mistakes’
Korea holds concert for Nigerian K-pop enthusiasts in Abuja
Only PhD students eligible to bring dependants to UK – Envoy reiterates
Air Force kills several terrorists in Borno, Niger airstrikes
ADVERTISEMENT
